Under 35 U.S.C. § 112(a) , a patent must contain a written description of the invention that is sufficient to demonstrate that the inventor had possession of the claimed invention at the time of filing. This requirement ensures that an applicant does not claim more than what was actually invented and disclosed. UNDERSTANDING THE WRITTEN DESCRIPTION REQUIREMENTS
In biotech and pharmaceutical patents , the challenge lies in describing biological molecules, genetic sequences and complex therapeutic mechanisms with enough specificity.
Made with FlippingBook Annual report maker